Promoter Methylation of RASSF1A indicates Prognosis for Patients with Stage II and III Colorectal Cancer Treated with Oxaliplatin-Based Chemotherapy.

about

Aloe-Emodin Induces Endoplasmic Reticulum Stress-Dependent Apoptosis in Colorectal Cancer Cells Identification and Interaction Analysis of Molecular Markers in Colorectal Cancer by Integrated Bioinformatics Analysis

P2860

Q58753998-6EDD13CC-ACDA-4C48-AB6E-7112DA6D893D Q58780656-C4CCAB80-F4B8-47BF-889A-E175220C0964

P2860

Promoter Methylation of RASSF1A indicates Prognosis for Patients with Stage II and III Colorectal Cancer Treated with Oxaliplatin-Based Chemotherapy.

Item

http://www.wikidata.org/entity/Q45382726

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Promoter Methylation of RASSF1 ...... xaliplatin-Based Chemotherapy.

@en

Promoter Methylation of RASSF1 ...... xaliplatin-Based Chemotherapy.

@nl

type

Item

label

Promoter Methylation of RASSF1 ...... xaliplatin-Based Chemotherapy.

@en

Promoter Methylation of RASSF1 ...... xaliplatin-Based Chemotherapy.

@nl

prefLabel

Promoter Methylation of RASSF1 ...... xaliplatin-Based Chemotherapy.

@en

Promoter Methylation of RASSF1 ...... xaliplatin-Based Chemotherapy.

@nl

P1476

Promoter Methylation of RASSF1 ...... Oxaliplatin-Based Chemotherapy

@en

P2093

Furong Hao

http://www.w3.org/2001/XMLSchema#string

Wei Yuan

http://www.w3.org/2001/XMLSchema#string

Wenzhen Zhuang

http://www.w3.org/2001/XMLSchema#string

Xicai Sun

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Global cancer statistics, 2012

The prognostic role of RASSF1A promoter methylation in breast cancer: a meta-analysis of published data.

Kras gene mutation and RASSF1A, FHIT and MGMT gene promoter hypermethylation: indicators of tumor staging and metastasis in adenocarcinomatous sporadic colorectal cancer in Indian population

Methylation of RASSF1A gene promoter and the correlation with DNMT1 expression that may contribute to esophageal squamous cell carcinoma

Methylation of the tumor suppressor gene RASSF1A in human tumors.

HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer

Aberrant Epigenetic Modifications of LPHN2 Function as a Potential Cisplatin-Specific Biomarker for Human Gastrointestinal Cancer.

Epigenetic resensitization to platinum in ovarian cancer

Loss of RASSF1A expression in colorectal cancer and its association with K-ras status.

P304

5389-5395

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.12659/MSM.903927

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29128865

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

5697441

http://www.w3.org/2001/XMLSchema#string

Promoter Methylation of RASSF1A indicates Prognosis for Patients with Stage II and III Colorectal Cancer Treated with Oxaliplatin-Based Chemotherapy.

about

P2860

P2860

Promoter Methylation of RASSF1A indicates Prognosis for Patients with Stage II and III Colorectal Cancer Treated with Oxaliplatin-Based Chemotherapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P932